Financial reports
10-Q
2003 Q2
Quarterly report
14 Aug 03
10-Q
2003 Q1
Quarterly report
15 May 03
10-K
2002 FY
Annual report
31 Mar 03
10-Q
2002 Q3
Quarterly report
14 Nov 02
10-Q
2002 Q2
Quarterly report
14 Aug 02
10-Q
2002 Q1
Quarterly report
15 May 02
10-K
2001 FY
Annual report
29 Mar 02
10-Q
2001 Q3
Quarterly report
14 Nov 01
10-Q
2001 Q2
Quarterly report
14 Aug 01
Current reports
8-K
Bankruptcy or receivership
22 Oct 03
8-K
Financial statements and exhibits
25 Jul 03
8-K
Financial statements and exhibits
30 Jun 03
8-K
Financial statements and exhibits
11 Jun 03
8-K
Bankruptcy or receivership
2 May 03
8-K
Essential Therapeutics Announces Delisting of its Common Stock from Nasdaq
14 Apr 03
8-K
Other events
24 Jan 03
8-K
Other events
14 Nov 02
8-K
Other events
10 Jun 02
8-K
Other events
25 Mar 02
Registration and prospectus
15-12G
Securities registration termination
12 Nov 03
S-3/A
Shelf registration (amended)
27 Dec 01
S-3
Shelf registration
21 Nov 01
S-8
Registration of securities for employees
15 Nov 01
S-8
Registration of securities for employees
1 Nov 01
S-8
Registration of securities for employees
1 Nov 01
S-3/A
Shelf registration (amended)
21 Mar 01
S-3
Shelf registration
9 Feb 01
S-8
Registration of securities for employees
30 Aug 00
S-8
Registration of securities for employees
1 Sep 99
Proxies
DEFA14A
Additional proxy soliciting materials
17 Jan 03
DEFA14A
Additional proxy soliciting materials
15 Jan 03
DEF 14A
Definitive proxy
3 Dec 02
PRE 14A
Preliminary proxy
13 Nov 02
DEF 14A
Definitive proxy
23 Apr 02
DEFM14A
Proxy related to merger
24 Sep 01
PRER14A
Preliminary revised proxy
12 Sep 01
PREM14A
Preliminary proxy related to merger
14 Aug 01
DEF 14A
Definitive proxy
18 May 01
DEF 14A
Definitive proxy
1 May 00
Other
No filings